About MLA Diagnostics
MLA Diagnostics is a company based in Amsterdam (Netherlands) founded in 2019.. MLA Diagnostics offers products and services including Melanoma Risk Assessment Tool and Molecular Assay.
- Headquarter Amsterdam, Netherlands
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Mla Diagnostics Bv
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$55.28 K (USD), Grant
Dec 09, 2019
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of MLA Diagnostics
MLA Diagnostics offers a comprehensive portfolio of products and services, including Melanoma Risk Assessment Tool and Molecular Assay. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
A multi-parameter non-invasive tool is utilized to assess melanoma risk by integrating molecular and clinical factors for identifying patients with high chances of recurrence.
An assay is employed in laboratory workflows to enhance clinical information and support decision-making for melanoma treatment strategies.
Funding Insights of MLA Diagnostics
- Total Funding Total Funding
- Total Rounds 1
- Last Round Grant — $55,276
-
First Round
First Round
(09 Dec 2019)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2019 | Amount | Grant - MLA Diagnostics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in MLA Diagnostics
MLA Diagnostics has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include EIT Health. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare startups are accelerated and incubated through specialized programs.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by MLA Diagnostics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - MLA Diagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Mla Diagnostics Comparisons
Competitors of MLA Diagnostics
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about MLA Diagnostics
When was MLA Diagnostics founded?
MLA Diagnostics was founded in 2019.
Where is MLA Diagnostics located?
MLA Diagnostics is headquartered in Amsterdam, Netherlands.
Who is the current CEO of MLA Diagnostics?
Egbert Smit is the current CEO of MLA Diagnostics.
What does MLA Diagnostics do?
MLA Diagnostics was founded in 2019 in Amsterdam, Netherlands. Operations are conducted in the healthcare diagnostics sector, with a focus on oncology. Diagnostic tests for detecting melanoma malignancy are developed and provided. Leadership is provided by CEO Egbert Smit. Activities are centered on advancing detection technologies for skin cancer applications in the European market.
What products or services does MLA Diagnostics offer?
MLA Diagnostics offers Melanoma Risk Assessment Tool and Molecular Assay.
Who are MLA Diagnostics's investors?
MLA Diagnostics has 1 investor. Key investors include EIT Health.